RSS Feed
Targacept Selling is Just Silly: BioBuzz
Profit taking today misses blockbuster potential for anti-depression drug.
12:57PM 12/03/09
Targacept Partners with Astra in Blockbuster Drug Deal
AztraZeneca is to pay up to $1.24 billion to secure global rights to Targacept's anti-depressant drug.
06:40AM 12/03/09
Hemispherx's Ampligen Dealt FDA Blow
Hemispherx BioPharma said the Food and Drug Administration refused to approve the experimental drug Ampligen for use in patients with chronic fatigue syndrome.
09:58AM 12/02/09
FDA Approves Two New Drugs: BioBuzz
Dyax and Merck/Santarus get FDA approvals. The U.S. Food and Drug Administration approved two drugs Tuesday night -- a prescription drug for a rare, genetic disorder and an over-the-counter treatment for heartburn.
07:30AM 12/02/09
Protalix-Pfizer Tag Team Against Genzyme: BioBuzz
New partnership for Gaucher's drug takes aim at Genzyme.
10:09AM 12/01/09
Research Firm Lays Out Surprise Bio Events for 2010: BioBuzz
Stocks will move if any of these unexpected events come true.
11:16AM 11/30/09
Biotech Calendar: Key Dates for December
A calendar of important, potentially stock-moving biotech events for December.
09:56AM 11/30/09
Biotech Stock Mailbag: Targacept
Targacept's depression drug TC-5214 makes it a great candidate to land a lucrative partnership from Big Pharma.
06:00AM 11/27/09
Cel-Sci's History of Disappearing Drugs: BioBuzz
Will Cel-Sci's flu drug last longer than its other fly-by-night projects?
09:20AM 11/24/09
BioCryst Bull Blames Conspiracy for Stock's Fall: BioBuzz
Hedge funds, Wall Street, SEC and FDA out to hurt maker of flu drug, newsletter writer claims.
06:45AM 11/24/09
Connect with TheStreet